Euthyroid Sick Syndrome: Causes, Diagnosis, and When to Treat

The direct answer

Euthyroid sick syndrome describes abnormal thyroid blood tests, not thyroid disease. During serious illness, surgery, or severe caloric deficit, peripheral conversion of T4 to active T3 is suppressed, reverse T3 rises, and TSH can move in either direction depending on illness phase. The thyroid gland itself is functioning normally. The clinically important question is not whether the labs look abnormal during illness, but whether that abnormality reflects a temporary illness response or a separate, coexisting thyroid disease that needs its own workup and treatment. Randomized trial evidence in critically ill adults has not shown that giving thyroid hormone during this state improves survival or recovery, which is why endocrine specialty groups generally advise against routine treatment. This is a stable point across the literature, but the underlying question of whether low T3 during illness is a protective adaptation or a harmful state that happens to correlate with worse illness is still unresolved, and it shapes how confidently anyone can generalize this advice to every clinical context.

What is established, what is plausible, and what is not established

Established: During acute systemic illness, peripheral conversion of T4 to T3 falls, reverse T3 rises, and total T3 drops, often within the first day. Thyroid function tests are frequently abnormal in hospitalized and critically ill patients who have no underlying thyroid disease. Thyroid hormone replacement trials in critically ill populations have not demonstrated a consistent mortality or recovery benefit. Major thyroid specialty guidance advises against routine thyroid hormone treatment for this pattern outside of research protocols.

Plausible but unproven: That T3 suppression is a protective, energy-conserving adaptation rather than simply a marker of how sick someone is. That treating a specific subgroup (for example, patients with the most severe or most prolonged illness, or a narrow surgical population such as pediatric cardiac surgery) might show a benefit that broader trials in mixed ICU populations have not detected. Whether short-term T3 support around cardiopulmonary bypass changes hemodynamics in a way that matters for outcomes remains an open, actively studied question rather than a settled one.

Not established: That low T3 during illness causes worse outcomes rather than simply accompanying them. That reverse T3 measurement reliably distinguishes ESS from true hypothyroidism across labs and assay platforms; assay variability limits this claim. That any specific numeric lab cutoff (a T3 threshold, an odds ratio, a percentage of ICU patients affected) reported in older literature can be applied confidently to a given hospital's assay and patient population without checking the primary source. Where this article referenced specific numbers from older secondary summaries, those numbers require verification against the primary literature before being used clinically or quoted as fact, and they are presented below only in general terms for that reason.

How the thyroid axis changes during illness

Three hormonal shifts characterize ESS, and they do not all happen at the same time or in every patient.

T3 falls first. Peripheral conversion of T4 to active T3 depends on deiodinase enzymes, and inflammatory signaling during acute illness suppresses this conversion. Serum total T3 typically drops within the first day of a significant illness, while reverse T3, an inactive breakdown product, tends to rise in parallel.

Free T4 usually holds, then can fall in prolonged illness. In mild-to-moderate illness, free T4 typically stays within the normal range. In prolonged or severe critical illness, free T4 can eventually fall as TSH pulsatility and hypothalamic drive diminish. A falling free T4 in a prolonged ICU course is generally viewed as a marker of higher illness severity rather than a separate diagnosis to treat.

TSH moves in both directions depending on phase. TSH can be suppressed during the acute phase of illness and then rebound, sometimes above the normal range, during recovery. A modestly elevated TSH measured shortly after a serious illness is more often a sign of the thyroid axis recovering than a new diagnosis of hypothyroidism, but this needs confirmation with repeat testing rather than an assumption in either direction.

Medications commonly used in hospitalized and critically ill patients, including glucocorticoids and dopamine, can independently suppress TSH, which compounds the difficulty of interpreting thyroid labs drawn during an ICU stay.

Adaptation or harm: the unresolved question

There are two competing ways to read the association between low T3 and poor outcomes in sick patients. One view holds that reducing T3 availability lowers metabolic demand and may be protective when the body's substrate supply is limited, a hypothesis partly supported by animal studies of sepsis. The other view notes that low T3 levels correlate with worse outcomes across many observational studies of critically ill patients, which is also consistent with T3 simply tracking how sick someone is rather than causing the bad outcome.

Both readings are defensible from current evidence, and the field has not resolved which is correct. That uncertainty is exactly why interventional trials, not observational correlations, are the evidence that should guide a treatment decision.

Should thyroid hormone be given during critical illness?

The interventional evidence, taken as a whole, has not shown a benefit. Randomized trials of thyroid hormone supplementation (T3 or T4) in critically ill adult and pediatric populations, including cardiac surgery and burn populations, have generally not found improvements in mortality, ventilator time, or length of stay. Because this article cannot verify the exact trial sizes and statistics originally cited without access to the primary papers, it states the direction of the evidence rather than specific numbers: multiple randomized trials point the same way, and no large, high-certainty trial has reversed that direction.

One area that remains genuinely unsettled is short-term T3 support around cardiac surgery requiring cardiopulmonary bypass, where T3 levels drop sharply after bypass and small trials have suggested a hemodynamic effect. Whether that translates into better outcomes, and in which patients, is still being studied, and this is a decision for a cardiac or intensive care specialist in an individual case rather than a routine practice.

Because thyroid hormone replacement is not FDA-approved for treating illness-related low T3 patterns, any use of it in this setting would be off-label and, based on current trial evidence, is not supported as routine care outside of a research protocol or a specific, individualized situation guided by an endocrinologist or intensivist.

Distinguishing ESS from true hypothyroidism, including Hashimoto's disease

This is the most consequential diagnostic question, because treating ESS as hypothyroidism exposes a patient to unnecessary lifelong medication, while missing true hypothyroidism delays needed treatment.

Thyroid antibodies. A positive thyroid peroxidase antibody (TPO-Ab) result raises the likelihood of underlying autoimmune thyroid disease, such as Hashimoto's thyroiditis, occurring alongside the acute illness. TPO-Ab is not expected to be positive in ESS itself.

TSH trajectory over time. In autoimmune hypothyroidism, TSH tends to be persistently elevated and to rise further over months without treatment. In ESS, an elevated TSH seen during illness recovery tends to fall back toward normal on repeat testing once the illness has resolved. Repeating TSH and free T4 several weeks after discharge, once the patient is clinically well, is the most reliable way to tell the two apart.

Free T4 level. A clearly low free T4 in someone who is not acutely or critically ill is more suggestive of true thyroid failure than of ESS, since free T4 is usually preserved in mild-to-moderate illness-related suppression.

Reverse T3. An elevated reverse T3 with a low T3-to-reverse-T3 ratio is more consistent with ESS than with primary hypothyroidism, but reverse T3 assays vary between laboratories and are not standardized, so this test should support a clinical impression rather than establish the diagnosis alone.

General clinical practice, reflected in thyroid specialty guidance, is to defer thyroid function testing during acute illness unless there is a specific clinical reason to suspect thyroid disease, precisely because the illness-phase labs are hard to interpret in isolation.

Avoiding overtreatment: ESS and subclinical hypothyroidism

Subclinical hypothyroidism is defined as an elevated TSH with a normal free T4 and no clear symptoms. During recovery from acute illness, a transiently elevated TSH can look identical to subclinical hypothyroidism on a single blood draw. Patients who have their TSH checked while hospitalized sometimes leave with a new levothyroxine prescription based on a single abnormal value that would have normalized on its own.

The U.S. Preventive Services Task Force does not recommend screening for thyroid dysfunction in asymptomatic adults (USPSTF, thyroid dysfunction screening; recommendation status as of the Task Force's most recent posted review, so check the page directly for the current date and wording). Checking TSH in an acutely ill hospitalized patient without a specific clinical reason increases the chance of exactly this kind of transient, illness-related abnormality being mistaken for a new diagnosis.

ESS overlapping with Graves' disease

In a patient with known Graves' disease or one taking antithyroid medication such as methimazole or propylthiouracil (PTU), illness-related T3 suppression can be superimposed on the underlying hyperthyroid pattern, which complicates interpretation in both directions. PTU also independently inhibits peripheral T4-to-T3 conversion, a mechanism that overlaps with the illness-driven suppression seen in ESS. In this specific situation, free T3 and thyroid-stimulating immunoglobulin levels, read together with the clinical exam, are generally more informative than total T3 or TSH alone, and this situation usually warrants direct endocrinology input rather than a lab-only interpretation.

Caloric restriction, fasting, and GLP-1 therapy

Severe caloric restriction produces a mild ESS-like pattern even outside of illness. Very-low-calorie diets have been reported to lower T3 within roughly two weeks of restriction, with a parallel rise in reverse T3; exact percentage changes vary by study and should be verified against the specific trial before being quoted as a fixed figure.

This is relevant to patients on GLP-1 receptor agonists such as semaglutide, since substantial and sustained weight loss implies an ongoing caloric deficit. A patient on this class of medication who reports fatigue or cold intolerance may be experiencing a fasting-related thyroid pattern rather than new hypothyroidism, and this possibility is worth raising with a clinician before assuming a new thyroid diagnosis, though it does not rule out the need for a standard thyroid workup if symptoms persist.

Selenium deficiency, more common in restrictive diets and in critically ill patients, can impair the enzymes that convert T4 to T3, compounding the T3 deficit seen in ESS. Correcting a documented selenium deficiency is reasonable on its own merits, though it is not established as a treatment for ESS itself.

A practical lab approach

No single lab value diagnoses ESS. The pattern across several tests, read against the clinical picture, is what supports the diagnosis.

When ESS is suspected, a reasonable set of tests includes: TSH, free T4 (with awareness that binding protein changes during illness can affect immunoassay accuracy), total T3, reverse T3 where available, TPO antibody to screen for coexisting autoimmune thyroid disease, and cortisol to help exclude adrenal insufficiency, which independently suppresses TSH.

Repeat testing after the illness has resolved, generally several weeks after discharge, resolves most diagnostic uncertainty and avoids exposing patients to thyroid medication they may not need. A single abnormal TSH or free T4 drawn during an acute hospitalization should not, by itself, be treated as confirmation of a permanent thyroid diagnosis.

A decision framework for interpreting thyroid labs drawn during illness

This is an educational framework to organize thinking, not a validated clinical algorithm and not a substitute for an endocrinology consult in an individual case.

Step 1: Is the patient currently acutely ill, post-operative, or severely calorie-restricted? If yes, expect thyroid labs to be unreliable for diagnosing new thyroid disease. If no, standard thyroid disease workup applies without the ESS caveats below.

Step 2: Classify the pattern by severity, and match the next step, not a treatment.

• Mild pattern: Low total T3, normal free T4, TSH normal or mildly low. Next step: no thyroid treatment; recheck labs after the illness resolves rather than during the acute phase.
• Moderate pattern: Low total T3, low-normal free T4, TSH suppressed (illness context is clear). Next step: no thyroid treatment; document the illness context; avoid same-admission thyroid hormone initiation.
• Severe or prolonged pattern: Low T3, low free T4, markedly suppressed or undetectable TSH in a prolonged critical illness. Next step: endocrinology consultation; thyroid hormone use, if considered at all, belongs in a research protocol or an individualized specialist decision, not a routine order.

Step 3: Check for red flags that argue against "just ESS." Positive TPO antibody, a free T4 clearly below the normal range in a patient who is not critically ill, a TSH that keeps rising rather than normalizing on repeat testing weeks after recovery, or a history of known thyroid disease. Any of these should prompt a standard thyroid disease workup in parallel with, not instead of, the illness explanation.

Step 4: Confirm before treating. Do not finalize a new hypothyroidism diagnosis, and do not start levothyroxine, based on labs drawn during the acute illness alone. Repeat TSH and free T4 after clinical recovery, generally several weeks later, before treating a persistent abnormality as a new permanent diagnosis.

Exception to hold in mind: a patient with a strong pre-existing reason to suspect thyroid disease (known Hashimoto's or Graves' disease, prior thyroid surgery or radioactive iodine, new atrial fibrillation with a hyperthyroid picture, or altered mental status suggestive of myxedema) should not have their workup delayed on the assumption that abnormal labs are "just" ESS. The framework above assumes no such pre-existing suspicion.

Long COVID and other prolonged illness states

Some patients recovering from significant infections, including COVID-19, have shown transient thyroid function abnormalities during the acute illness that resolve over the following months without thyroid-directed treatment. Persistent fatigue after a serious illness has many possible causes, including deconditioning, sleep disruption, dysautonomia, and iron deficiency, and attributing it to thyroid dysfunction based on labs drawn during the acute illness risks both overdiagnosis and delay in identifying the actual cause. A thyroid panel repeated well after recovery, not during the acute illness, is the more informative test if thyroid dysfunction is still suspected.

Recovery and follow-up

Recovery from ESS generally follows resolution of the underlying illness, without thyroid-directed therapy, in the large majority of patients. After minor illness or surgery, thyroid labs often normalize within one to two weeks. After a prolonged critical illness, full recovery of the thyroid axis can take considerably longer, and a modestly elevated TSH measured a few weeks after a long ICU stay should generally be rechecked before being labeled as subclinical hypothyroidism, rather than treated immediately.

Anyone who received a provisional thyroid diagnosis while hospitalized should have that diagnosis reassessed with repeat labs after recovery, ideally with their own physician, before treatment is considered permanent.

When to seek care rather than wait

Urgent evaluation is appropriate for symptoms suggesting a true thyroid emergency rather than illness-related lab drift: new confusion or profound lethargy with signs suggesting myxedema, new rapid or irregular heartbeat with signs of thyroid storm in a patient with known hyperthyroidism, or any acute change that a treating clinician flags as inconsistent with the expected illness course. These situations call for direct evaluation by the treating medical team, not self-directed thyroid hormone use of any kind.